𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor

✍ Scribed by Tomoki Origuchi; Naoki Iwamoto; Shin-ya Kawashiri; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Kazuhiko Arima; Hideki Nakamura; Satoshi Yamasaki; Hiroaki Ida; Atsushi Kawakami; Yukitaka Ueki; Naoki Matsuoka; Munetoshi Nakashima; Akinari Mizokami; Yojiro Kawabe; Masanobu Mine; Takaaki Fukuda; Katsumi Eguchi


Publisher
Springer
Year
2010
Tongue
English
Weight
334 KB
Volume
21
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Circulating levels of tumor necrosis fac
✍ Derek L. Mattey; John R. Glossop; Nicola B. Nixon; Peter T. Dawes πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 2 views

## Abstract ## Objective To investigate whether circulating levels of soluble tumor necrosis factor receptors (sTNFR) are predictive of mortality in rheumatoid arthritis (RA). ## Methods Levels of sTNFRI and sTNFRII at study entry were quantified using enzyme‐linked immunosorbent assays in sera